Evaluation of the hypotensive potential of bovine and porcine collagen hydrolysates

Journal of Medicinal Food

Volumn 11, Issue 3, 2008, Pages 560-567

  Faria, Mariza ^a   Da Costa, Elizabete Lourenço ^a   Gontijo, José Antônio Rocha ^a   Netto, Flávia Maria ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Angiotensin converting enzyme; Antihypertensive activity; Arterial blood pressure; Capillary electrophoresis; In vitro digestion; Spontaneously hypertensive rat; Systolic blood pressure

Indexed keywords

COLLAGEN DERIVATIVE; LISINOPRIL; PROTEIN HYDROLYSATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; COW; DIGESTION; DRUG BIOAVAILABILITY; DRUG POTENCY; HYDROLYSIS; HYPOTENSION; IC 50; MALE; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SWINE; ULTRAFILTRATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; CATTLE; COLLAGEN; HYPERTENSION; MALE; PROTEIN HYDROLYSATES; RABBITS; RATS; RATS, INBRED SHR; SWINE;

BOVINAE; RATTUS; SUS;

EID: 52149094380     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2007.0573     Document Type: Article

References (29)

1. Erdos EG: Angiotensin I-converting enzyme. Circ Res 1975;36:247-255.
2. Skeggs LT, Kahn JE, Shumway NP: The preparation and function of the angiotensin-converting enzyme. J Exp Med 1956;103:295-299.
3. Vermeirssen V, Camp JV, Verstraete W: Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br J Nutr 204;92:357-366.
4. Antonios TF, MacGregor GA: Angiotensin converting enzyme inhibitors in hypertension: potential problems. J Hypertens Suppl 1995;13:S11-S16.
5. Fitzgerald RJ, Meisel H: Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr Suppl 2000;84:S33-S37.
6. Cheng HS, Wang FL, Ondetti MA, Sabo EF, Cushman DW: Binding of peptide substrate and inhibition of angiotensin-converting enzyme: importance of the COOH-terminal dipeptides sequence. J Biol Chem 1980;255:401-407.
7. Fahmi A, Morimura S, Guo HC, Shigematsu T, Kida K, Uemura Y: Production of angiotensin I converting enzyme inhibitory peptides from sea bream scales. Process Biochem 2004;39:1195-1200.
8. Byun HG, Kim SK: Structure and activity of angiotensin I converting enzyme inhibitory peptides derived from Alaska pollack skin. J Biochem Mol Biol 2002;35:239-243.
9. Saiga A, Okumura T, Makihara T, Katsuta S, Shimizu T, Yamada R, Nishimura T: Angiotensin I-converting enzyme inhibitory peptides in a hydrolyzed chicken breast muscle extract. J Agric Food Chem 2003;51:1741-1745.
10. Kim SK, Byun HG, Park PJ, Shahidi F: Angiotensin I converting enzyme inhibitory peptides purified from bovine skim gelatin hydrolysate. J Agric Food Chem 2001;49:2992-2997.
11. th ed. Association of Official Analytical Chemists, Arlington, VA, 1995.
12. Adler-Nissen J: Determination of the degree of hydrolysis of food protein hydrolysates by trinitrobenzenesulfonic acid. J Agric Food Chem 1979;27:1256-1262.
13. Adler-Nissen J: Enzymatic Hydrolysis of Food Proteins. Elsevier Applied Science Publishers Ltd., London, 1986.
14. Pacheco MTB, Amaya-Farfan J, Sgarbieri VC: Partial characterization of a whey protein concentrate and its enzyme hydrolysates. J Food Biochem 2002;26:327-338.
15. Shihabi ZK: Analysis of angiotensin-converting enzyme by capillary electrophoresis. J Chromatogr A 1999;853:185-188.
16. Costa EL, Gontijo JAR, Netto FM: Effect of heat and enzymatic treatment on the antihypertensive activity of whey protein hydrolysates. Int Dairy J 2007;17:632-640.
17. Lovenberg W: Techniques for the measurement of blood pressure. Hypertension 1987;9:5-6.
18. Vermeirssen V, Camp JV, Devos L, Verstraete W: Release of angiotensin I converting enzyme (ACE) inhibitory activity during in vitro gastrointestinal digestion: from batch experiment to semicontinuous model. J Agric Food Chem 2003;51:5680-5687.
19. Panyam D, Kilara A: Enhancing the functionality of food proteins by enzymatic modification. Trends Food Sci Technol 1996;7:120-125.
20. Wu J, Ding X: Characterization of inhibition and stability of soy-protein-derived angiotensin I-converting enzyme inhibitory peptides. Food Res Int 2002;35:367-375.
21. Hyun CK, Shin HK: Utilization of bovine blood plasma proteins for the production of angiotensin I converting enzyme inhibitory peptides. Process Biochem 2000;36:65-71.
22. Abubakar A, Saito T, Kitazawa H, Kawai Y, Itoh T: Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion. J Dairy Sci 1998;81:3131-3138.
23. Pihlanto-Leppälä A, Koskinen P, Piilola K, Tupasela T, Korhonen H: Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. J Dairy Res 2000;67:53-64.
24. Cha M, Park JR: Production and characterization of a soy protein-derived angiotensin I-converting enzyme inhibitory hydrolysate. J Med Food 2005;8:305-310.
25. Otte J, Samah MS, Mila Z, Are HP, Sayed AE: Angiotensin-converting enzyme inhibitory activity of milk protein hydrolysates: effect of substrate, enzyme and time of hydrolysis. Int Dairy J 2007;17:488-503.
26. Chiang W-D, Tsou M-J, Tsai, Z-Y, Tsai, T-C: Angiotensin I-converting enzyme inhibitor derived from soy protein hydrolysate and produced by using membrane reactor. Food Chem 2006;98:725-732.
27. Pihlanto-Leppälä A: Bioactive peptides derived from bovine whey proteins: opioid and ace-inhibitory peptides. Trends Food Sci Technol 2001;11:347-356.
28. Fujita H, Yamagami T, Ohshima K: Effects of an ACE-inhibitory agent, katsuobushi oligopeptide, in the spontaneously hypertensive rat and in borderline and mildly hypertensive subjects. Nutr Res 2001;21:1149-1158.
29. Murakami M, Tonouchi H, Takahashi R, Kitazawa H, Kawai Y, Negishi H, Saito T: Structural analysis of a new anti-hypertensive peptide (β-lactosin B) isolated from a commercial whey product. J Dairy Sci 2004;87:1967-1974.